A carregar...
Multiple Sclerosis Treatment and Melanoma Development
Therapy of multiple sclerosis (MS) with disease-modifying agents such as natalizumab or fingolimod has been associated with the development of cutaneous melanoma. Here we briefly revise literature data and report of a case of a 48-year old woman who developed a melanoma and several atypical naevi af...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7216218/ https://ncbi.nlm.nih.gov/pubmed/32331328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21082950 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|